xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">
http://newsobserver.com/wednesday/news/Story/825918p-817260c.html
Firms file suits
over mercury in vaccines
|
|
|
|
|
|
|
|
|
STORY TOOLS
|
|
|
|
|
|
printer friendly version
send this story to a friend
|
|
|
|
|
|
SITE TOOLS
|
|
|
|
|
|
subscribe to our e-mail lists
get news, weather, movies on your PDA
|
|
|
|
|
|
|
|
|
|
By WILLIAM MCCALL, The Associated Press
PORTLAND, Ore. -- A
coalition of law firms went to court across the nation Tuesday, trying to force
the pharmaceutical industry to study whether vaccines containing a trace of
mercury cause autism and other brain damage in young children.
The lawsuits were filed as
class actions and led by an Oregon woman who says her 3-year-old son, William,
became autistic after getting vaccinations containing mercury in a
preservative, thimerosal.
"We had a happy,
healthy little boy until that last set of shots," Tory Mead said.
"It's been devastating. Our lives have been shattered."
Michael Williams, the lead
attorney, said drug companies did not tell doctors how much mercury was
contained in the vaccines until Congress ordered the Food and Drug
Administration to find out in 1997.
"When they added it
up, they were shocked to find out it was way above the safe level for an adult,
let alone babies or very young children," Williams said.
He said thimerosal was used
simply as a way to reduce the cost of the vaccine. It was needed to preserve
larger bottles that would be used repeatedly. If the drug companies had offered
the vaccine in small, disposable vials for individual use, no preservative
would have been needed, Williams said.
Today, few vaccines given
to children in the United States contain thimerosal. The suit seeks to make
sure any remaining stocks are removed.
The law firm representing
Mead formed a coalition of more than 35 law firms across the country
representing families in at least 25 states. The suits' immediate goal is
getting the industry to study whether the mercury caused the brain problems;
damages could be sought if such a link is established.
Spokesmen for the firms
said the lawsuits were being filed Tuesday in nine states -- California,
Connecticut, Maine, Maryland, New Hampshire, Pennsylvania, Virginia, Washington
and West Virginia. Suits already have been filed in Oregon and Massachusetts.
The lawsuits were announced
the day after the National Academy of Sciences released a report saying
researchers still are unable to determine if there is a link between thimerosal
and disorders in children.
But the report concluded
that "the effort to remove thimerosal from vaccines was a prudent measure
in support of the public health goal to reduce the mercury exposure of infants
and children as much as possible."
In July 1999, the American
Academy of Pediatrics joined the U.S. Public Health Service to warn that
vaccines containing thimerosal should be removed as soon as possible.
The defendants in the
lawsuits include Aventis Pasteur Inc.; Pasteur Merieux Connaught; Pfizer Inc.,
a subsidiary of Warner-Lambert; GlaxoSmithKline; Merck & Co.; Abbott
Laboratories; American Home Products; Wyeth-Ayerst Laboratories; Lederle
Laboratories; Baxter International Inc., Eli Lilly & Co.; Integra Chemical
Co.; Sigma Chemical Co.; and Aldrich Chemical Co. Three doctors, including one
who treated Mead's son, also were named as defendants.
A spokeswoman for Merck had
no comment. Spokeswomen for Abbott and for Baxter International said the
companies acquired subsidiaries that made vaccines, and had little involvement
with its manufacture.
Calls to other defendants
were not immediately returned.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR
OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING
MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN
IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN
CONSULTATION WITH YOUR HEALTH CARE PROVIDER.